A Safety and Efficacy Study of STSP-0601 in Adult Patients With Hemophilia A or B With Inhibitor

NCT05027230 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia

Interventions

DRUG: STSP-0601 for Injection
DRUG: STSP-0601 for Injection

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd